RXR Is an Essential Component of the Oncogenic PML/RARA Complex In Vivo

Cancer Cell

Volumn 12, Issue 1, 2007, Pages 23-35

  Zhu, Jun ^a,b   Nasr, Rihab ^a   Pérès, Laurent ^a   Riaucoux Lormière, Florence ^a   Honoré, Nicole ^a   Berthier, Caroline ^a   Kamashev, Dmitrii ^a   Zhou, Jun ^a,b   Vitoux, Dominique ^a   Lavau, Catherine ^a   de Thé, Hugues ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

CELLCYCLE; DNA

Indexed keywords

RETINOID X RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CHROMATIN; DNA BINDING; GRANULOCYTE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SUMOYLATION; TRANSCRIPTION REGULATION;

MUS MUSCULUS;

EID: 34347270506     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2007.06.004     Document Type: Article

References (59)

1. Altucci L., Rossin A., Hirsch O., Nebbioso A., Vitoux D., Wilhelm E., Guidez F., Schiavone E.M., Grimwade D., Zelent A., et al. Rexinoid-triggered differentiation and tumours selective apoptosis of AML by protein kinase-A-mediated de-subordination of RXR. Cancer Res. 65 (2005) 8754-8765
2. Benedetti L., Grignani F., Scicchitano B.M., Jetten A.M., Diverio D., Lo Coco F., Avvisati G., Gambarcoti-Passerini C., Adamo S., Levin A.A., et al. Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RAR alpha-mediated increase of type II transglutaminase. Blood 87 (1996) 1939-1950
3. Benoit G., Altucci L., Flexor M., Ruchaud S., Lillehaug J., Raffelsberger W., Gronemeyer H., and Lanotte M. RAR-independent RXR signaling induces t(15;17) leukemia cell maturation. EMBO J. 18 (1999) 7011-7018
4. Brown D., Kogan S., Lagasse E., Weissman I., Alcalay M., Pelicci P.G., Atwater S., and Bishop J.M. A PML RAR alpha transgene initiates murine acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA 94 (1997) 2551-2556
5. Calleja C., Messaddeq N., Chapellier B., Yang H., Krezel W., Li M., Metzger D., Mascrez B., Ohta K., Kagechika H., et al. Genetic and pharmacological evidence that a retinoic acid cannot be the RXR-activating ligand in mouse epidermis keratinocytes. Genes Dev. 20 (2006) 1525-1538
6. Choi S.J., Chung S.S., Rho E.J., Lee H.W., Lee M.H., Choi H.S., Seol J.H., Baek S.H., Bang O.S., and Chung C.H. Negative modulation of RXRalpha transcriptional activity by small ubiquitin-related modifier (SUMO) modification and its reversal by SUMO-specific protease SUSP1. J. Biol. Chem. 281 (2006) 30669-30677
7. de Thé H., Vivanco-Ruiz M.M., Tiollais P., Stunnenberg H., and Dejean A. Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature 343 (1990) 177-180
8. de Thé H., Lavau C., Marchio A., Chomienne C., Degos L., and Dejean A. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66 (1991) 675-684
9. Du C., Redner R.L., Cooke M.P., and Lavau C. Overexpression of wild-type retinoic acid receptor alpha (RAR alpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RAR alpha-fusion genes. Blood 94 (1999) 793-802
10. Duprez E., Saurin A.J., Desterro J.M., Lallemand-Breitenbach V., Howe K., Boddy M.N., Solomon E., de Thé H., Hay R.T., and Freemont P.S. SUMO-1 modification of the acute promyelocytic leukaemia protein PML: Implications for nuclear localisation. J. Cell Sci. 112 (1999) 381-393
11. Germain P., Iyer J., Zechel C., and Gronemeyer H. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature 415 (2002) 187-192
12. Gianni M., Tarrade A., Nigro E.A., Garattini E., and Rochette-Egly C. The AF-1 and AF-2 domains of RAR gamma 2 and RXR alpha cooperate for triggering the transactivation and the degradation of RAR gamma 2/RXR alpha heterodimers. J. Biol. Chem. 278 (2003) 34458-34466
13. Grignani F., Ferrucci P., Testa U., Talamo G., Fagioli M., Alcalay M., Mencarelli A., Grignani F., Peschle C., Nicoletti I., and Pelicci P. The acute promyelocytic leukemia specific PML/RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74 (1993) 423-431
14. Grignani F., de Matteis S., Nervi C., Tomassoni L., Gelmetti V., Cioce M., Fanelli M., Ruthardt M., Ferrara F.F., Zamir I., et al. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 391 (1998) 815-818
15. Guillemin M.C., Raffoux E., Vitoux D., Kogan S., Soilihi H., Lallemand-Breitenbach V., Zhu J., Janin A., Daniel M.T., Gourmel B., et al. In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia. J. Exp. Med. 196 (2002) 1373-1380
16. Hansen L.A., Brown D., Virador V., Tanaka T., Andreola F., Strain K., Dancheck B., Riley R., Arbeit J.M., De Luca L.M., et al. A PMLRARA transgene results in a retinoid-deficient phenotype associated with enhanced susceptibility to skin tumorigenesis. Cancer Res. 63 (2003) 5257-5265
17. Hay R.T. SUMO: A history of modification. Mol. Cell 18 (2005) 1-12
18. Huang T.T., Wuerzberger-Davis S.M., Wu Z.H., and Miyamoto S. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 115 (2003) 565-576
19. Jansen J.H., Mahfoudi A., Rambaud S., Lavau C., Wahli W., and Dejean A. Multimeric complexes of the PML-retinoic acid receptor alpha fusion protein in acute promyelocytic leukemia cells and interference with retinoid and peroxisome-proliferator signaling pathways. Proc. Natl. Acad. Sci. USA 92 (1995) 7401-7405
20. Johnson B.S., Chandraratna R.A.S., Heyman R.A., Allegretto E.A., Mueller L., and Collins S.J. Retinoid X receptor (RXR) agonist-induced activation of dominant-negative RXR-retinoic acid receptor alpha 403 heterodimers is developmentally regulated during myeloid differentiation. Mol. Cell. Biol. 19 (1999) 3372-3382
21. Kamashev D.E., Vitoux D., and De Thé H. PML/RARA-RXR oligomers mediate retinoid- and rexinoid-/cAMP in APL cell differentiation. J. Exp. Med. 199 (2004) 1-13
22. Kamitani T., Kito K., Nguyen H.P., Wada H., Fukuda-Kamitani T., and Yeh E.T.H. Identification of three major sentrinization sites in PML. J. Biol. Chem. 41 (1998) 26675-26682
23. Kastner P., Perez A., Lutz Y., Rochette-Egly C., Gaub M.-P., Durand B., Lanotte M., Berger R., and Chambon P. Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): Structural similarities with a new family of oncoproteins. EMBO J. 11 (1992) 629-642
24. Kastner P., Mark M., and Chambon P. Nonsteroid nuclear receptors: What are genetic studies telling us about their role in real life?. Cell 83 (1995) 859-869
25. Kogan S.C., Ward J.M., Anver M.R., Berman J.J., Brayton C., Cardiff R.D., Carter J.S., de Coronado S., Downing J.R., Fredrickson T.N., et al. Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood 100 (2002) 238-245
26. Kuriyan J. Allostery and coupled sequence variation in nuclear hormone receptors. Cell 116 (2004) 354-356
27. Kwok C., Zeisig B.B., Dong S., and So C.W. Forced homo-oligomerization of RARalpha leads to transformation of primary hematopoietic cells. Cancer Cell 9 (2006) 95-108
28. Lallemand-Breitenbach V., Guillemin M.-C., Janin A., Daniel M.-T., Degos L., Kogan S.C., Bishop J.M., and de Thé H. Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia. J. Exp. Med. 189 (1999) 1043-1052
29. Lallemand-Breitenbach V., Zhu J., Puvion F., Koken M., Honore N., Doubeikovsky A., Duprez E., Pandolfi P.P., Puvion E., Freemont P., and de Thé H. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As(2)O(3)-induced PML or PML/retinoic acid receptor alpha degradation. J. Exp. Med. 193 (2001) 1361-1372
30. Lane A.A., and Ley T.J. Neutrophil elastase cleaves PML-RARalpha and is important for the development of acute promyelocytic leukemia in mice. Cell 115 (2003) 305-318
31. Lavau C., Heard J.M., Danos O., and Dejean A. Retroviral vectors for the transduction of the PML-RARalpha fusion product of acute promyelocytic leukemia. Exp. Hematol. 24 (1996) 544-551
32. Li M., Indra A.K., Warot X., Brocard J., Messaddeq N., Kato S., Metzger D., and Chambon P. Skin abnormalities generated by temporally controlled RXRalpha mutations in mouse epidermis. Nature 407 (2000) 633-636
33. Licht J.D. Reconstructing a disease: What essential features of the retinoic acid receptor fusion oncoproteins generate acute promyelocytic leukemia?. Cancer Cell 9 (2006) 73-74
34. Lin R.J., Nagy L., Inoue S., Shao W.L., Miller W.H., and Evans R.M. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 391 (1998) 811-814
35. Lin R., and Evans R. Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers. Mol. Cell 5 (2000) 821-830
36. Mann K.K., Padovani A.M., Guo Q., Colosimo A.L., Lee H.Y., Kurie J.M., and Miller Jr. W.H. Arsenic trioxide inhibits nuclear receptor function via SEK1/JNK-mediated RXRalpha phosphorylation. J. Clin. Invest. 115 (2005) 2924-2933
37. Matsushita H., Scaglioni P.P., Bhaumik M., Rego E.M., Cai L.F., Majid S.M., Miyachi H., Kakizuka A., Miller Jr. W.H., and Pandolfi P.P. In vivo analysis of the role of aberrant histone deacetylase recruitment and RAR alpha blockade in the pathogenesis of acute promyelocytic leukemia. J. Exp. Med. 203 (2006) 821-828
38. Minucci S., Maccarana M., Cioce M., De Luca P., Gelmetti V., Segalla S., Di Croce L., Giavara S., Matteucci C., Gobbi A., et al. Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation. Mol. Cell 5 (2000) 811-820
39. Muller S., Matunis M.J., and Dejean A. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J. 17 (1998) 61-70
40. Perez A., Kastner P., Sethi S., Lutz Y., Reibel C., and Chambon P. PML/RAR homodimers: Distinct binding properties and heteromeric interactions with RXR. EMBO J. 12 (1993) 3171-3182
41. Quenech'Du N., Ruchaud S., Khelef N., Guiso N., and Lanotte M. A sustained increase in the endogenous level of cAMP reduces the retinoid concentration required for APL cell maturation to near physiological levels. Leukemia 12 (1998) 1829-1833
42. Rusten L.S., Dybedal I., Blomhoff H.K., Blomhoff R., Smeland E.B., and Jacobsen S.E. The RAR-RXR as well as the RXR-RXR pathway is involved in signaling growth inhibition of human CD34+ erythroid progenitor cells. Blood 87 (1996) 1728-1736
43. Saitou M., Sugai S., Tanaka T., Shimouchi K., Fuchs E., Narumiya S., and Kakizuka A. Inhibition of skin development by targeted expression of a dominant-negative retinoic acid receptor. Nature 374 (1995) 159-162
44. Sell S. Leukemia: Stem cells, maturation arrest, and differentiation therapy. Stem Cell Rev. 1 (2005) 197-205
45. Shao W., Benedetti L., Lamph W.W., Nervi C., and Miller W.H.J. A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation. Blood 89 (1997) 4282-4289
46. Shiohara M., Dawson M.I., Hobbs P.D., Sawai N., Higuchi T., Koike K., Komiyama A., and Koeffler H.P. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro. Blood 93 (1999) 2057-2066
47. Srinivas H., Juroske D.M., Kalyankrishna S., Cody D.D., Price R.E., Xu X.C., Narayanan R., Weigel N.L., and Kurie J.M. c-Jun N-terminal kinase contributes to aberrant retinoid signaling in lung cancer cells by phosphorylating and inducing proteasomal degradation of retinoic acid receptor alpha. Mol. Cell. Biol. 25 (2005) 1054-1069
48. Sternsdorf T., Phan V.T., Maunakea M.L., Ocampo C., Sohal J., Siletto A., Galimi F., Le Beau M.M., Evans R., and Kogan S. Forced retinoic acid receptor a homodimer prime mice for APL-like leukemia. Cancer Cell 9 (2006) 81-94
49. Takano Y., Adachi S., Okuno M., Muto Y., Yoshioka T., Matsushima-Nishiwaki R., Tsurumi H., Ito K., Friedman S.L., Moriwaki H., et al. The RING finger protein, RNF8, interacts with retinoid X receptor alpha and enhances its transcription-stimulating activity. J. Biol. Chem. 279 (2004) 18926-18934
50. Tarrade A., Bastien J., Bruck N., Bauer A., Gianni M., and Rochette-Egly C. Retinoic acid and arsenic trioxide cooperate for apoptosis through phosphorylated RXR alpha. Oncogene 24 (2005) 2277-2288
51. Taschner S., Koesters C., Platzer B., Jorgl A., Ellmeier W., Benesch T., and Strobl H. Down-regulation of RXRα expression is essential for neutrophil development from granulocyte/monocyte progenitors. Blood 109 (2007) 971-979 10.1182/blood-2006-04-020552 Published online October 3, 2006
52. Ulrich H.D. Mutual interactions between the SUMO and ubiquitin systems: A plea of no contest. Trends Cell Biol. 15 (2005) 525-532
53. Verger A., Perdomo J., and Crossley M. Modification with SUMO. A role in transcriptional regulation. EMBO Rep. 4 (2003) 137-142
54. Warrell R., de Thé H., Wang Z., and Degos L. Acute promyelocytic leukemia. N. Engl. J. Med. 329 (1993) 177-189
55. Westervelt P., Lane A.A., Pollock J.L., Oldfather K., Holt M.S., Zimonjic D.B., Popescu N.C., DiPersio J.F., and Ley T.J. High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression. Blood 102 (2003) 1857-1865
56. Zhou J., Peres L., Honore N., Nasr R., Zhu J., and de Thé H. Dimerization-induced corepressor binding and relaxed DNA-binding specificity are critical for PML/RARA-induced immortalization. Proc. Natl. Acad. Sci. USA 103 (2006) 9238-9243
57. Zhu J., Gianni M., Kopf E., Honore N., Chelbi-Alix M., Koken M., Quignon F., Rochette-Egly C., and de Thé H. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RAR alpha) and oncogenic RAR alpha fusion proteins. Proc. Natl. Acad. Sci. USA 96 (1999) 14807-14812
58. Zhu J., Zhou J., Peres L., Riaucoux F., Honore N., Kogan S., and de Thé H. A sumoylation site in PML/RARA is essential for leukemic transformation. Cancer Cell 7 (2005) 143-153
59. Zimmerman T.L., Thevananther S., Ghose R., Burns A.R., and Karpen S.J. Nuclear export of retinoid X receptor alpha in response to interleukin-1beta-mediated cell signaling: Roles for JNK and SER260. J. Biol. Chem. 281 (2006) 15434-15440